SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-236597
Filing Date
2018-08-02
Accepted
2018-08-02 16:17:10
Documents
47
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d500486d10q.htm 10-Q 368704
2 EX-10.6 d500486dex106.htm EX-10.6 19377
3 EX-31.1 d500486dex311.htm EX-31.1 6382
4 EX-31.2 d500486dex312.htm EX-31.2 6401
5 EX-32 d500486dex32.htm EX-32 4156
  Complete submission text file 0001193125-18-236597.txt   2951995

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT itci-20180630.xml EX-101.INS 587410
7 XBRL TAXONOMY EXTENSION SCHEMA itci-20180630.xsd EX-101.SCH 30119
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itci-20180630_cal.xml EX-101.CAL 39345
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itci-20180630_def.xml EX-101.DEF 126323
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20180630_lab.xml EX-101.LAB 303727
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20180630_pre.xml EX-101.PRE 218330
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36274 | Film No.: 18988563
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences